Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jardiance in type 2 diabetes mellitus (EMPATROPHY)
NCT02728453Phase 4Terminated
- Sponsor
- Hannover Medical School
- Start
- Apr 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Hannover Medical School. Started Apr 2016; status: terminated.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02728453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728453.